Keywords: Mylan, Astellas, Prograf, Teva, Copaxone

Mylan gets US approval for copy version of Astellas’ immunosuppressant Prograf; Teva files complaint over Copaxone patents

Article | 22 September 2010

Print This

US generic drug major Mylan (Nasdaq: MYL) says that its subsidiary Mylan Pharmaceuticals has received final approval from the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in